Article -> Article Details

India Pharmaceutical Manufacturing Market Report

According to IMARC Group’s report titled "India Pharmaceutical Manufacturing Market Size, Share, Trends and Forecast by Molecule Type, Drug Development Type, Formulation, Route of Administration, Therapy Area, Prescription, Age Group, Sales Channel, and Region, 2025-2033" the report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.

Note : We are in the process of updating our reports to cover the 2026–2034 forecast period. For the most recent data, insights, and industry updates, please click on "Request Free Sample Report".

Request Free Sample Report: https://www.imarcgroup.com/india-pharmaceutical-manufacturing-market/requestsample

India Pharmaceutical Manufacturing Market Overview

The India pharmaceutical manufacturing market size reached USD 19.25 Billion in 2024. The market is projected to grow to USD 35.13 Billion by 2033, exhibiting a Compound Annual Growth Rate (CAGR) of 6.91% during the forecast period 2025-2033. The market growth is fueled by cost-effective production, strong domestic demand, government policies such as the PLI scheme, and robust global export opportunities, especially for generics and biosimilars. The report presents a thorough review featuring the India pharmaceutical manufacturing market size, growth, share, trends, and research of the industry.

India Pharmaceutical Manufacturing Market Key Takeaways

• Current Market Size: USD 19.25 Billion in 2024
• CAGR: 6.91% during 2025-2033
• Forecast Period: 2025-2033
• India's pharmaceutical manufacturing is cost-effective due to affordable labor, infrastructure, and utility charges.
• India supplies over 20% of the global generic medicines market.
• Strong domestic API supply chain supports robust production capabilities.
• Large skilled workforce from premier institutions enhances productivity and innovation.
• The country hosts the highest number of US FDA-approved pharmaceutical plants outside the US.

India Pharmaceutical Manufacturing Market Growth Factors

• Strong government support including initiatives like the Production Linked Incentive (PLI) scheme promotes growth.
• Rising demand for affordable healthcare solutions domestically and globally fuels expansion.
• Cost-effective production capacity enables competitive pricing compared to Western countries.
• Robust export opportunities for generics and biosimilars drive market growth.
• A well-established medical infrastructure backed by extensive R&D expertise supports innovation.
• Increasing global aging population and treatment expenditure boosts demand for generics and biosimilars.
• India’s compliance with WHO-GMP, US FDA, and EU regulations increases international manufacturing attractiveness.
• Steady supply of skilled professionals such as chemists, pharmacists, and biotechnologists enhances sector productivity.
• Improvements and investments in advanced technologies, including continuous manufacturing and biotech platforms accelerate growth.

Buy the Latest 2026 Edition: https://www.imarcgroup.com/checkout?id=33217&method=1337

India Pharmaceutical Manufacturing Market Trends

• India’s pharmaceutical sector is one of the most cost-effective manufacturing hubs globally due to its lower labor costs and affordable infrastructure.
• International pharmaceutical companies often outsource or establish manufacturing facilities in India for cost reduction without compromising quality.
• Facilities approved by WHO-GMP and adhering to US FDA and EU standards enhance the country's reputation for quality.
• India is recognized as the "Pharmacy of the World" by supplying more than 20% of global generic medicines.
• Indian companies excel in reverse engineering and rapid process improvement, enabling fast generic manufacturing post patent expiry.
• The country maintains the largest number of US FDA-approved manufacturing plants outside the US, reinforcing trustworthiness.
• Large pools of scientifically qualified manpower contribute to both productivity and innovation in pharmaceutical manufacturing.
• Premier institutions such as Indian Institutes of Technology (IITs) and National Institutes of Pharmaceutical Education and Research (NIPERs) continuously supply skilled labor.
• Government policies and continuous technological enhancements keep India competitive in the global pharmaceutical manufacturing market.

India Pharmaceutical Manufacturing Market Segmentation

Molecule Type Insights:

• Biologics and Biosimilars (Large Molecules): Monoclonal Antibodies, Vaccines, Cell and Gene Therapy, Others
• Conventional Drugs (Small Molecules)

Detailed analysis of large molecule biologics and small molecule conventional drugs with breakdowns.

Drug Development Type Insights:

• In-House
• Outsource

Market categorized by in-house and outsourcing drug development.

Formulation Insights:

• Tablets
• Capsules
• Injectable
• Sprays
• Suspensions
• Powders
• Others

Comprehensive formulation types covered including solid, injectable, and other forms.

Route of Administration Insights:

• Oral
• Topical
• Parenteral
• Inhalations
• Others

Analysis based on different administration routes.

Therapy Area Insights:

• Cardiovascular Diseases (CVDs)
• Pain
• Diabetes
• Cancer
• Respiratory Diseases
• Others

Market coverage of major therapy segments.

Prescription Insights:

• Prescription Medicines
• Over-the-counter (OTC) Medicines

Segment by prescription status.

Age Group Insights:

• Children and Adolescents
• Adults
• Geriatric

Categorization by patient age group.

Sales Channel Insights:

• Retail
• Non-Retail

Sales channels distribution.

Regional Insights

• North India
• South India
• East India
• West India

The market is dominated by North India, reflecting the largest market share driven by manufacturing hubs, skilled workforce, and infrastructure, achieving an overall CAGR of 6.91% during the forecast period.

India Pharmaceutical Manufacturing Market Key Players

The report offers an in-depth examination of the competitive landscape, including market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

India Pharmaceutical Manufacturing Market Recent Developments & News

• November 2024: ACG Engineering launched the ADAPT X feeder at CPhI & PMEC India 2024, enhancing packaging efficiency by handling complex tablet shapes with high-speed, tool-less changeovers.
• November 2024: Clariant introduced eight high-performing excipients at CPhI India 2024, including the VitiPure LEX series and Polyglykol 1450 S, combining Swiss expertise with local manufacturing.
• November 2024: Pfizer announced expanding manufacturing and R&D capacities in India by relocating oncology and chemotherapy production to Gujarat and increasing R&D staff in Chennai, with nearly 70% of its Indian sales manufactured domestically.

India Pharmaceutical Manufacturing Market Key Highlights of the Report

• Comprehensive quantitative analysis of market segments and trends from 2019-2033.
• Insights into market drivers, challenges, and opportunities.
• Porter's five forces analysis to assess industry competition and attractiveness.
• Detailed competitive landscape with key player positioning and strategy analysis.
• Extensive company profiles of major market participants.

Get Your Customized Market Report Instantly: https://www.imarcgroup.com/request?type=report&id=33217&flag=E

Customization Note: If you require any specific information not covered within this report’s scope, we will provide it as part of the customization.

About Us

IMARC Group is a global management consulting firm that helps ambitious changemakers create a lasting impact. The company offers comprehensive market assessment, feasibility studies, incorporation support, regulatory assistance, branding and strategy services, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel: (D) +91 120 433 0800

United States: +1-201971-6302